Skip to content

Ultrasound Guided Erector Spinae Plane Block in Breast Surgery

Effect of Hyalorounidase on the Spread of Local Anaesthetics in Erector Spinae Plane Block

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03660020
Enrollment
60
Registered
2018-09-06
Start date
2018-05-19
Completion date
2020-12-31
Last updated
2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

hyalorounidase will be added to local anaesthetics in patients undergoing mastectomy and effect on local anaesthetic spread will be studied under floroscope

Detailed description

two groups will be enrolled the control group will receive local anaethetic only and the spread will be observed by floroscope. the seconed group, hyaloronidase will be added to local anaesthetics and the spread will be studied under image.

Interventions

DRUGLocal anesthetic

ultrasound guided erector spine plane block (ESP) will be done in patients under going mastectomy with local anaesthetics only

hyaluronidase will be added to ultrasound guided erector spine plane block (ESP) will be done in patients under going mastectomy

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Female 2. ASA I, II, III 3. Elective surgery

Exclusion criteria

1. Patient refusal 2. Infection at injection site 3. Allergy to the given drugs

Design outcomes

Primary

MeasureTime frameDescription
degree of local anaesthetics spread after injection in both group10 minutes after blockspread of local anaesthics will be examined under floroscopic guide

Countries

Egypt

Contacts

Primary Contactrasha HAMED
rashaahmed11@yahoo.com088-01000440773
Backup Contactsaeid elsawy
saeedelsawy17@gmail.com088-01030072161

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026